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ABSTRACT
Numerous mRNAs are degraded in processing bodies (P bodies) in
Saccharomyces cerevisiae. In logarithmically growing cells, only 0–1
P bodies per cell are detectable. However, the number and
appearance of P bodies change once the cell encounters stress.
Here, we show that the polysome-associated mRNA-binding protein
Scp160 interacts with P body components, such as the decapping
protein Dcp2 and the scaffold protein Pat1, presumably, on
polysomes. Loss of either Scp160 or its interaction partner Bfr1
caused the formation of Dcp2-positive structures. These Dcp2-
positive foci contained mRNA, because their formation was inhibited
by the presence of cycloheximide. In addition, Scp160 was required
for proper P body formation because only a subset of bona fide P
body components could assemble into the Dcp2-positive foci in
Dscp160 cells. In either Dbfr1 or Dscp160 cells, P body formation was
uncoupled from translational attenuation as the polysome profile
remained unchanged. Collectively, our data suggest that Bfr1 and
Scp160 prevent P body formation under normal growth conditions.
KEY WORDS: Processing bodies, mRNA, mRNA metabolism,
Endoplasmic reticulum, Translation, Saccharomyces cerevisiae,
mRNA-binding proteins, mRNA decay, Stress response,
Ribonucleotide particles, Stress granules
INTRODUCTION
The protein content in a cell at any given time is regulated by
transcription, translation and protein degradation. Transcription
largely determines the number of mRNA molecules, whereas the
balance of mRNA translation and protein degradation is
important for the regulation of protein homeostasis. Upon
encountering stress, a cell needs to quickly alter its proteome,
thus, as a type of primary response to stress, translation often
becomes attenuated. Consequently, mRNAs that are no longer
engaged in translation are frequently stored in processing bodies
(P bodies) (Parker and Sheth, 2007). P bodies consist of the
decapping enzymes Dcp1 and Dcp2, the helicase Dhh1, activators
of decapping – such as Pat1, Scd6, Edc3 and the Lsm1–7
complex – and the 59-39 exonuclease Xrn1 (Parker and Sheth,
2007). In addition to this basic assortment of P body components,
an ever-growing list of proteins associated with P bodies has been
reported (Jain and Parker, 2013; Mitchell et al., 2013; Parker and
Sheth, 2007).
To date, P bodies have been reported to be involved in mRNA
decapping, nonsense-mediated decay, translational repression,
mRNA storage and other RNA related functions (Parker and
Sheth, 2007). The transcripts that are stored in P bodies are in a
dynamic exchange with the pool of mRNAs undergoing
translation and can either be degraded or be bound by
ribosomes for translation.
P bodies are not the only ribonucleoprotein (RNP) structures
that are formed upon stress. Numerous stress conditions also
promote the formation of stress granules. Stress granules are
mainly composed of stalled translation initiation components and
are sites of mRNA storage. The analysis of the different RNP
structures is complicated by the fact that numerous factors are
found in both types of granules, such as the exonuclease Xrn1
(Buchan and Parker, 2009). In addition, mRNA can traverse from
P bodies into stress granules and vice versa (Buchan et al., 2008).
Moreover, P bodies and stress granules are found in close contact
to each other, which might facilitate the transfer of components
and mRNA.
In yeast, 59-to-39 decay of mRNA appears to be the major
direction of mRNA degradation (Muhlrad et al., 1995; Shoemaker
and Green, 2012). Once the cell encounters stress, P bodies
become visible by microscopy, which is thought to occur through
the aggregation of P body components that are, presumably,
bound to mRNA. These aggregates are, nevertheless, highly
dynamic and can dissolve either upon adaptation of the cell to the
stressor or when the stress ceases to exist (Brengues et al., 2005;
Teixeira and Parker, 2007). Depending upon the stress that is
encountered, the size and number of P bodies varies. For
example, glucose starvation induces a few relatively large foci,
whereas high salt and high Ca2+ cause the formation of smaller
but more numerous P bodies (Brengues et al., 2005; Kilchert
et al., 2010). The reason for the different responses is not clear. It
has to be noted, however, that glucose starvation can only be
remedied by the addition of a good carbon source, whereas cells
can adapt to stresses such as high salt (Ashe et al., 2000;
Brengues et al., 2005). As a consequence, P bodies that form
under such stress disassemble after adaptation (Kilchert et al.,
2010).
P bodies are found in close proximity to, and might even be
physically linked to, the endoplasmic reticulum (ER) (Kilchert
et al., 2010). To determine whether P bodies are physically linked
to the ER, we aimed to identify proteins that bind to P body
components. The peripheral ER proteins Scp160 and Bfr1 were
identified as interacting proteins of P bodies. The association of
Scp160 and Bfr1 with polysomes prompted us to test whether
Scp160 and Bfr1 might play a role in P body formation. Our
results suggest that Bfr1 and Scp160 act independently as
negative regulators of P body formation at the ER. Moreover, our
data imply that Scp160 is required for the correct assembly of P
bodies.
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RESULTS
Screen for novel P-body-interacting proteins at the
endoplasmic reticulum
We have shown previously that P bodies are localized in close
proximity to ER membranes (Kilchert et al., 2010). In order to
identify potential ER-localized interaction partners of P body
components, we employed tandem affinity purification after
crosslinking with the P body components Dcp2 and Scd6, which
are part of the 59UTR- and the 39UTR-associated complexes of P
bodies, respectively. We chose a crosslinking approach because P
bodies are highly dynamic, and their interaction with the ER
could be transient (Teixeira and Parker, 2007). We also opted for
a stringent method and, therefore, selected the HBH tag for the
purification scheme. The HBH tag consists of a biotinylation
sequence, which is flanked by two His6 peptides, allowing
tandem purification under denaturing conditions (Tagwerker
et al., 2006).
The temperature-sensitive arf1-11 mutation in the small
GTPase Arf1p causes the formation of numerous P bodies at
the restrictive temperature (Kilchert et al., 2010). Cultures of
arf1-11 mutants expressing chromosomally tagged Dcp2–HBH or
Scd6–HBH and wild-type cells were shifted to 37 C˚ for 1 h to
induce P bodies. Protein complexes were crosslinked in vivo,
extracted from membrane pellets that had been enriched for ER
membranes, and purified over Ni-NTA and streptavidin beads
under denaturing conditions. The proteins were digested, and the
peptides analyzed by mass spectrometry. This approach was
successful because we could identify P body components in our
purification scheme (Table 1). In addition, proteins were
identified that were neither present in the untagged wild-type
control nor in other HBH purifications for unrelated baits that
have been performed by our group (Ritz et al., 2014). Those
proteins present only in the Dcp2–HBH or Scd6–HBH sample, or
in both samples, were considered for further analysis (Table 1).
Bfr1 and Scp160 are newly identified P-body-interacting
proteins at the ER
Three of the proteins identified in the tandem affinity
purifications were ER-associated proteins – Bfr1, Scp160 and
Cdc48. Cdc48 is a AAA-ATPase that is involved in homotypic
membrane fusion during karyogamy, and in the extraction and
retro-translocation of polypeptides from the ER that are destined
for degradation by the proteasome (Hitchcock et al., 2001;
Latterich et al., 1995; Schuberth and Buchberger, 2005). The
function of Cdc48 in ER-associated degradation might mean that
it also transmits a signal to induce P body formation under ER
stress conditions. We decided, however, to focus on the two other
proteins Scp160 and Bfr1. Scp160 is an mRNA-binding protein
that, together with Bfr1, associates with actively translating
polysomes at the ER (Lang et al., 2001). Loss of Scp160 causes
mislocalization of the asymmetrically localized ASH1 mRNA
(Irie et al., 2002; Trautwein et al., 2004) and SRO7 mRNA after
pheromone treatment (Gelin-Licht et al., 2012). Bfr1 has been
identified as a multicopy suppressor of brefeldinA-induced
lethality (Jackson and Ke´pe`s, 1994). However, the molecular
function of Bfr1 is still unknown.
First, we established whether Scp160 and Bfr1 are still
associated with the ER at 37 C˚, the temperature at which we
performed the crosslink. To this end, we appended both Scp160
and Bfr1 chromosomally with a GFP tag in strains that expressed
the ER marker Sec63 that had been tagged with red fluorescent
protein (RFP). Both proteins remained associated with the ER,
irrespective of the temperature (23 C˚ or 37 C˚) or the strain
background (wild-type or arf1-11) (Fig. 1).
Because we used a crosslinking approach to detect proteins that
interact with P body components, we wanted to ensure that
Scp160 and Bfr1 were not just localized in the vicinity of P
bodies and therefore caught in the complex, and that Scp160 and
Bfr1 were also able to interact with P body components in the
absence of crosslinking agents. 36 FLAG tagged Scp160 co-
immunoprecipitated Dcp2 that had been tagged with nine repeats
of a Myc epitope (9Myc), irrespective of whether the cells were
stressed by glucose starvation, high intracellular Ca2+ or
unstressed (Fig. 2A,B). The association of Bfr1 with Dcp2 was
detected to a lower extent, and the levels were more variable,
indicating that Dcp2 might interact primarily with Scp160 rather
than with Bfr1. Given that Scp160 is an RNA-binding protein and
interacts with the machinery that stores and decays mRNAs, we
next tested whether the interaction between Scp160 and Dcp2
was dependent on mRNA. Indeed, treatment of yeast lysates with
RNase strongly reduced the amount of co-immunoprecipitated
Dcp2 (Fig. 2C).
To explore the possibility that other P body components could
also interact with Scp160 and/or Bfr1, we repeated the
Table 1. Proteins identified by HBH-purification
Found only in Dcp2-HBH Found only in Scd6-HBH Found in both purifications
Nog1 Sbp1 Dcp2
Hta1 Eap1 Xrn1
Atp1 Not1 Edc3
Cdc48** Rps12 Scd6
Hef3 Bfr1**
Hsp12 Dhh1
Tif5 Tef4
Scp160** Sti1
Yra1 Pab1
Tif3 Cpr1
Psp2 Nam7
Lsm5 Pat1
Lsm2 Def1
Dcp1 Vma13
Hsp26
Mpg1
Bold formatting indicates P body components, italic formatting indicates RNA-related function, ** indicates ER association.
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immunoprecipitations and probed for Pat1 and Edc3, both of
which had been tagged with six repeats of the HA epitope (Pat1–
6HA and Edc3–6HA, respectively), without stress or under
glucose starvation (Fig. 2D). Similar to Dcp2, Pat1 and Edc3
were part of a complex that was associated with, at least, Scp160–
FLAG. In all cases, the stress seemed to slightly, but consistently,
increase the interaction of Scp160 with these P body components.
By contrast, Scd6–6HA was not co-immunoprecipitated
with Scp160–FLAG (Fig. 2D). The ability of Scp160 to interact
with P body components appeared to be independent of stress,
indicating that induction of stress is not a prerequisite for the
interaction of P body components with Scp160. Because Dcp2
and Pat1 play a more prominent role in P body assembly
(Teixeira and Parker, 2007), our data suggest that at least partially
assembled P bodies could be present on actively translating
ribosomes. We conclude that Scp160 is a newly identified
mRNA-dependent protein that interacts with P body components
at the ER.
Scp160 and Bfr1 are not required for the localization of P
bodies to the ER
P bodies localize in close proximity to the ER (Kilchert et al.,
2010). Therefore, we asked whether Scp160 and Bfr1 are required
for P body localization at the ER. Dcp2–9Myc-positive structures
were detected by immunoelectron microscopy as being in close
proximity to the ER in both the Dbfr1 and Dscp160 cells, or in the
wild type, when shifted to 37 C˚ (Fig. 3A). The distribution of the
Dcp2–9Myc signal, which was suggestive of a ring-like globular
structure, was similar in both strains. We then used a biochemical
assay to investigate further the results of the ultrastructural
analysis. We have shown previously that Dcp2–9Myc co-
migrates with ER membranes in a sucrose gradient (Kilchert
et al., 2010); here, the association of Dcp2 with the ER was not
drastically altered in either of the deletion strains (Fig. 3B) –
similar amounts of Dcp2–9Myc floated at the 0% to 40% sucrose
interface. Our data demonstrate that neither Scp160 nor Bfr1 are
essential for the recruitment of Dcp2 to ER membranes.
P body components co-fractionate with polysomes
independently of Scp160 or Bfr1
Bfr1 and Scp160 have been shown to be associated with
polysomes (Lang et al., 2001), therefore, we asked whether P
body components could be recruited to polysomes. We
fractionated polysomes from wild-type, Dscp160, Dbfr1 and
Dbfr1 Dscp160 cells on a sucrose gradient and subjected the
polysome fractions to immunoblot analysis. As previously
observed (Baum et al., 2004; Li et al., 2003), we did not find a
significant change in the polysome profile or an increase in the
80S monosome fraction in any of the strains, which would be
indicative of translation attenuation (Fig. 4A). In all cases, Dcp2–
9Myc and Scd6–6HA were detected in the polysome fraction
(Fig. 4A); thus, association of P body components with the
polysomes is independent of Bfr1 and Scp160.
P bodies were not induced in the wild-type cells under the
growth conditions that were used for the experiment; therefore,
our data indicate that P body components are associated with
polysomes during translation in normal logarithmically growing
cells. We noticed that Dcp2–9Myc was detected as a double band
by immunoblotting, and that, in the fractions of the Dscp160
Dbfr1 polysome profile, the upper band was strongly reduced.
Fig. 1. Bfr1p and Scp160 are
identified as potential interacting
proteins of P bodies at the ER. Bfr1
and Scp160 localize to the ER. Strains
were created in which Bfr1 and Scp160
were chromosomally tagged with GFP
(in a background of ARF1 or arf1-11, the
latter induces P body formation at the
restrictive temperature). These strains
were then transformed with a plasmid
encoding Sec63–RFP (red) to label the
ER. Cells were observed at 23˚C and
after a 1 h shift to 37˚C to mimic the
conditions that had been used for the
HBH purification. At both temperatures,
Bfr1–GFP and Scp160–GFP (green)
localized to ER membranes. Scale
bars: 5 mm.
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 1992–2004 doi:10.1242/jcs.142083
1994
Jo
ur
na
l o
f C
el
l S
ci
en
ce
Thus, we tested whether the double band represented different
phosphorylation states. Phosphorylation of Dcp2 has been
previously reported, but no band shift in SDS gels had been
observed (Yoon et al., 2010). Treatment of the gradient fractions
with alkaline phosphatase caused the double band to collapse into
the lower molecular weight band (Fig. 4B). These data suggest
that phosphorylated and non-phosphorylated forms of Dcp2 are
present on polysomes.
P bodies are present on ER membranes, and Scp160 and Bfr1 are
enriched on ER-associated polysomes; yet, we used total yeast
lysate for the polysome profiles. It is conceivable that P body
components associate with the ER-bound polysomes in an
Scp160–Bfr1-dependent manner. Moreover, the phosphorylated
and dephosphorylated forms of Dcp2 might segregate between
membrane-bound and soluble polysomes. To test these hypotheses,
we recorded the polysome profiles of membrane and soluble
fractions (supplementary material Fig. S1). Immunoblotting
of the gradient fractions revealed that P body components could
bind to soluble and membrane-associated polysomes (Fig. 4A).
Interestingly, the ER-associated polysome pool was enriched for
the phosphorylated form of Dcp2 (Fig. 4A). Phosphorylation of
Dcp2 has been reported to be required for its accumulation in P
Fig. 2. Scp160 associates with P body
components independently of stress.
(A) Scp160 associates with Dcp2
independently of glucose starvation. Co-
immunoprecipitation experiments were
performed using an antibody against the
FLAG peptide and lysates from strains that
had been chromosomally tagged with
Scp160–3FLAG or Bfr1–3FLAG. All strains
also expressed Dcp2–9Myc. Where
indicated, cells were subjected to starvation
for 10 min (2D) before the
immunoprecipitation (IP). Dcp2–9Myc co-
precipitated with Scp160–3FLAG in both
conditions. A weak precipitation of Dcp2–
9Myc with Bfr1–FLAG was sometimes
observed. (B) Ca2+ stress does not affect the
Scp160–Dcp2 association. Cells were
treated with 200 mM CaCl2 for 10 min
(+Ca2+) and then a 5 min washout in rich
media without CaCl2 was performed before
lysate preparation. Under stressed and
unstressed conditions, Dcp2–9Myc co-
immunoprecipitated with Scp160–3FLAG.
(C) The association of Scp160 with Dcp2 is
lost in the absence of RNA. To determine if
RNA was needed for the interaction between
Scp160 and Dcp2, strains were treated as in
A and then subjected to treatment with
RNaseA for 1 h before immunoprecipitation.
Upon RNaseA treatment, the association of
Dcp2–9Myc with Scp160–3FLAG was no
longer observed under either condition.
(D) Scp160 associates with P body
components. Pat1, Edc3 or Scd6 were
chromosomally appended with a 6HA tag.
The strains were treated as in A. Scp160–
3FLAG was able to precipitate Pat1–6HA
and Edc3–6HA under both conditions but did
not precipitate
Scd6-6HA.
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bodies (Yoon et al., 2010), which is consistent with the notion that
P bodies are associated with ER membranes (Kilchert et al., 2010).
Notably, the amount of phosphorylated Dcp2 was reduced in the
soluble polysome pool in Dscp160 Dbfr1 cells, indicating that
Scp160 and Bfr1 together are required to maintain the Dcp2
phosphorylation state. Taken together, our data demonstrate that P
body components are associated with polysomes and suggest that
phosphorylated Dcp2 preferentially binds to membrane-associated
polysomes.
Loss of Bfr1 or Scp160 induces the formation of multiple
Dcp2-positive structures
The immunoelectron microscopy analysis revealed that, unlike in wild-
type cells, in the Dscp160 and Dbfr1 strains, Dcp2–9Myc-positive
structures were readily observed under normal non-stress growth
conditions (Fig. 3A, 23 C˚). This observation led us to determine
whether P bodies form in the mutant strains without any stress
being applied at the normal growth temperature. Indeed, when we
visualized Dcp2–GFP in the Dbfr1 and Dscp160 strains, and in the
Dbfr1 Dscp160 double mutant, we found a large increase in the
number of P bodies compared with the wild-type cells, which
typically contained 0–2 P bodies per cell (Fig. 5A,B;
supplementary material Fig. S2A). Importantly, this increase in
Dcp2-positive structures was restricted to normal growth
conditions. Shifting the mutant cells to 37 C˚, which causes a
mild temperature stress – as indicated by the small increase in P
body number in wild-type cells – reduced the number of the Dcp2-
positive structures in the mutant strains to below even that of the
Fig. 3. Loss of BFR1 or SCP160 does not impair P body association with the ER. (A) P bodies remain in close proximity to ER membranes in Dbfr1
and Dscp160 cells. Cells that expressed Dcp2–9Myc, in which BFR1 or SCP160 had been deleted, were grown at 23˚C and then shifted for 1 h to 37˚C. A
wild-type (WT) control is also shown. Cells were fixed and prepared for immunoelectron microscopy. Dcp2–9Myc was visualized by using gold particles. Scale
bars: 500 nm. The insets are a 26magnification of the area where the gold particles were found. White arrowheads indicate ER membranes. (B) Dcp2
associates with ER membranes in the absence of BFR1 or SCP160. Wild-type, Dbfr1 and Dscp160 yeast cells expressing Dcp2–9Myc were shifted to 37˚C for
1 h. Lysates were prepared, and a pellet was formed from a 13,000 g centrifugation (P13) and corresponding supernatant fraction (S13). The pellet was
subjected to buoyant density centrifugation. In all conditions, a portion of Dcp2–9Myc fractionated with the ER marker Sec61p at the 0% to 40% sucrose
interface (0/40).
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wild type (Fig. 5A,B). We aimed to phenocopy the effect of the
Dscp160 deletion by expressing an Scp160 C-terminal truncation
that has been shown previously to compromise Scp160 function
(Baum et al., 2004). The removal of the four most-C-terminal K
homology (KH) domains induced the formation of multiple Dcp2-
positive foci (Scp160 DC4, supplementary material Fig. S2B),
which is consistent with this truncation having been shown to be
hypersensitive to treatment with cycloheximide and the proposed
role of Scp160 in translation (Baum et al., 2004). Deletion of either
BFR1 or SCP160 causes a plethora of phenotypes; therefore, it is
possible that the P body phenotype is caused by stress due to
extended cultivation of the deletion strains. To rule out this
possibility, we replaced the endogenous promoter of SCP160 and
BFR1 with the inducible MET25 promoter, which is inhibited upon
addition of methionine to the growth medium. Under these growth
conditions, P body induction was still observed (supplementary
material Fig. S2C). Taken together, these data suggest that Scp160
and Bfr1 negatively regulate P body formation under normal
growth and stress-free conditions.
Loss of Scp160 or Bfr1 does not induce stress
granule formation
Given the increase of P bodies in Dbfr1 and Dscp160 cells and
that, under certain conditions, P body formation is coupled to
Fig. 4. P body components associate with polysomes. (A) Loss of BFR1 or SCP160 does not cause translation attenuation or dissociation of P body
components. Cells were grown to mid-log phase and subjected to polysome profile analysis. Despite the large increase in P body number in Dbfr1, Dscp160 and
Dbfr1Dscp160 cells at 23˚C, there was no attenuation in translation. Polysome profile fractions from total lysate, lysates containing membrane-associated
polysomes or soluble polysomes were TCA precipitated, analyzed by SDS-PAGE and blotted for the P body proteins Dcp2–9Myc and Scd6–6HA or the ribosomal
protein Rpl16a. The charts on the left show recordings of polysome profiles. M indicates monosome and P polysome fractions. In all cases, a portion of Dcp2–9Myc
and Scd6–6HA were found to associate with polysomes. M, monosome; P, polysome. (B) The double bands observed for Dcp2–9Myc is the result of
phosphorylation. Fractions of the polysome profile analysis were subjected to treatment with alkaline phosphatase. Upon alkaline phosphatase treatment, the upper
band was lost (black arrow) resulting in only the presence of the lower band (white arrow), indicating that the upper band was due to phosphorylation.
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 1992–2004 doi:10.1242/jcs.142083
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stress granule formation (Yoon et al., 2010), we next asked
whether the number of stress granules is also increased under
standard growth conditions in the mutant strains. Stress granule
formation has been demonstrated to occur under glucose
starvation and under heat stress (Buchan et al., 2008; Grousl
et al., 2009). As a marker for stress granule formation, we used
the polyU-binding protein Pub1p (Buchan et al., 2008). Indeed,
we observed stress granule formation in wild-type cells under
both conditions, whereas, in Dscp160 and Dbfr1 cells, stress
granules were only visible after heat stress (Fig. 5C,D). Thus,
Scp160 and Bfr1 might be required for stress granule formation
only under certain stresses. Consistently, the Dbfr1 and Dscp160
strains did not induce stress granule formation under standard
growth conditions (Fig. 5C,D); therefore, the phenotype of P
body induction in the Dbfr1 and Dscp160 strains is not strictly
coupled to stress granule formation.
Overexpression of SCP160 or BFR1 rescues the enhanced P
body formation phenotype of Dbfr1 or Dscp160, respectively
Bfr1 and Scp160 form a complex at actively translating
polysomes, and their localization at the ER is interdependent,
nevertheless, they have been shown to have distinct functions
(Lang et al., 2001). For example, only Scp160 binds mRNA,
and only Bfr1 causes resistance to brefeldinA when
overexpressed (Jackson and Ke´pe`s, 1994; Lang and
Fridovich-Keil, 2000; Weber et al., 1997). Moreover, Scp160,
rather than Bfr1, bound to the mRNA associated P body
components. We, therefore, wondered whether the interaction
of Scp160 with Bfr1 is required to prevent P body formation
under normal growth conditions, or whether Bfr1 and Scp160
can act independently. To distinguish between these
possibilities, we overexpressed SCP160 and BFR1 by using
the strong TEF1 promoter in the Dbfr1 and Dscp160 strains,
respectively. Both genes were also overexpressed, individually,
in the wild-type strain. In wild-type cells, the increased
expression caused both proteins to also localize to the
cytoplasm, indicating that the binding sites at the ER were
saturable (Fig. 6A). Overexpression of BFR1 in Dscp160 cells,
or SCP160 in Dbfr1 cells, reduced the number of Dcp2-positive
foci to that found in wild-type cells (Fig. 6B,C). This reciprocal
rescue was specific because overexpression of the unrelated
ArfGAP GLO3, under the control of the TEF1 promoter, did not
Fig. 5. Loss of BFR1 or SCP160 increases P body number under normal growth conditions. (A) Increased P body number was observed in Dbfr1,
Dscp160 and Dbfr1Dscp160 cells. Dcp2 was chromosomally tagged and used as a marker for P bodies. Under normal growth conditions at 23˚C in the wild-type
(WT) strain 0–2 P bodies were observed. Upon deletion of BFR1, SCP160 or both from the cell, the number of P bodies increased. (B) Quantification of the P
body phenotype observed in the wild-type and deletion strains upon temperature shift. A minimum of 200 cells from at least three independent experiments were
counted per condition. The size of the box is determined by the 25th and 75th percentiles, the whiskers represent the 5th and 95th percentiles, the horizontal line
and the triangle represent the median and mean, respectively. ***P,0.001, **P,0.01. (C) Stress granules failed to form in Dbfr1 or Dscp160 cells under
starvation conditions. Wild-type, Dbfr1 and Dscp160 cells were transformed with a high copy plasmid expressing the stress granule marker Pub1–mCherry. Cells
were grown to mid-log phase at 23˚C then shifted to 46˚C or incubated in rich media lacking a carbon source (2D) for 10 min. (D) Quantification of Pub1-positive
foci that were observed under various stresses. ***P,0.001. Scale bars: 5 mm.
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rescue the multiple-P-body phenotype in Dscp160 or Dbfr1
strains (supplementary material Fig. S2D); thus, merely
increasing the mRNA levels did not rescue the P body
phenotype. These data indicate that both Scp160 and Bfr1 are
able to independently prevent P body formation under normal
growth conditions.
Loss of Scp160 generates pseudo P bodies
So far we have shown that loss of Scp160 and Bfr1 induces Dcp2-
positive foci. P bodies are highly dynamic structures in which P
body components assemble in an aggregate-like manner, similar
to prions. In fact, a number of P body proteins contain prion-like
domains (Alberti et al., 2009; Reijns et al., 2008); thus, it would
be conceivable that, in the absence of Scp160 or Bfr1, proper P
bodies do not form. Given that the formation of P bodies requires
the presence of RNA in these structures (Coller and Parker, 2005;
Teixeira et al., 2005), we treated cells with cycloheximide, which
‘locks’ ribosomes onto mRNA and restricts the availability of the
mRNA for the formation of P bodies. As expected, treatment of
cells with cycloheximide abolished the Dcp2-positive foci in the
mutant strains (Fig. 7A), indicating that Dscp160 and Dbfr1 cause
the appearance of bona fide P bodies.
To expand our results, we determined the localization of three
additional P body constituents (Scd6, Edc3 and Dhh1) (Fig. 7B
and C). All of the markers formed multiple foci in Dbfr1 cells,
only a few Scd6- or Edc3-positive structures were observed in
Dscp160 cells and Dhh1 did not form foci that would correspond
to P-bodies. To demonstrate that the foci formed by the different
P body components associated with the same structures, we co-
expressed Dcp2–GFP and Edc3–mCherry (supplementary
material Fig. S2E). The localizations of the P body components
showed extensive overlap, indicating that they are, indeed,
present on the same structure. These data indicate that, in Dbfr1
cells, bona fide P bodies are formed in the absence of stress. By
contrast, loss of Scp160 led to the formation of aggregates that
lacked certain P body components, which we define as pseudo P
bodies. Our results suggest that Scp160 might play a role in the
assembly of P body proteins. Taken together, our data are
consistent with both Bfr1 and Scp160 being negative regulators of
P body formation in the absence of stress.
Scp160 and Bfr1 do not repress P body formation
under stress
We hypothesized that because Bfr1 and Scp160 associate with
actively translating polysomes, both proteins could prevent access
of P body components to mRNA during translation. During stress
conditions, under which translation is attenuated (Brengues et al.,
2005; Kilchert et al., 2010), it is possible that polysomes
disassemble and, therefore, that Scp160 and Bfr1 are lost from
the mRNA, which means that they cannot protect mRNA and
cannot be involved in the control of P body formation.
Consequently, the loss of Scp160 or Bfr1 should not affect P
body formation under such stress conditions. Upon withdrawal of
glucose from wild-type, Dscp160 or Dbfr1 cultures, we observed
P body induction to a similar extent in wild-type and Dbfr1 cells
(Fig. 7D and E). A small increase in the number of Dcp2-positive
Fig. 6. Overexpression of SCP160 or BFR1 rescues the Dcp2-foci
phenotype in the reciprocal deletion. (A) Overexpression of Bfr1–GFP
or Scp160–GFP led to saturation of ER sites, whereas Bfr1–GFP or Scp
160–GFP remained at the ER in TEF1-SCP160 or TEF1-BFR1 cells,
respectively. The endogenous promoters of BFR1 or SCP160 were
chromosomally exchanged for the constitutive TEF1 promoter and the
localization of Bfr1–GFP or Scp160–GFP was observed. (B) Dcp2-positive
foci were reduced in TEF1-SCP160 Dbfr1 or TEF1-BFR1 Dscp160 strains
compared with the deletions alone. BFR1 or SCP160 were overexpressed in
strains expressing Dcp2–GFP in which either SCP160 or BFR1 had been
deleted. (C) Quantification of the Dcp2-positive foci in cells shown in B. See
Fig. 5B for details on the representation. ***P,0.001, *P,0.05. Scale bars:
5 mm.
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structures was observed in the Dscp160 strain, consistent with a
role for Scp160 in the correct assembly of P bodies. A similar
result was obtained under heat stress (supplementary material Fig.
S3). Our results are consistent with Scp160 and Bfr1 having a
negative role on the formation of P bodies, but only in the
absence of stress.
DISCUSSION
P body formation is an important process by which eukaryotic
cells respond to a plethora of stresses, such as environmental,
metabolic and cellular stress. Here, we aimed to understand why
P bodies are localized in close proximity to the ER membrane.
We find that P body components interact with the polysome-
associated mRNA-binding protein Scp160. This interaction
exposes the P body components to mRNA molecules as soon as
they are released from the polysomes. Thus, the function of
Scp160, and its interacting protein Bfr1, is, probably, to keep the
P body components in a ‘waiting’ position but, nevertheless,
inhibit the formation of P bodies under normal growth and stress-
free conditions (Fig. 8). In this model, as soon as the cell
encounters stress, the protective function of Scp160 and Bfr1 is
lost, and P body components have unrestricted access to mRNAs.
We find that loss of either Bfr1 or Scp160 causes the formation
of multiple Dcp2-positive structures. Although both structures
contain mRNA, only the Dcp2-positive foci in Dbfr1 cells appear
to be fully assembled P bodies (Fig. 8). In Dscp160 cells, the
Dcp2-positive structures do not contain all of the P body
components and, hence, are probably not functional in terms of
mRNA decay. Thus, Scp160 appears to play a, perhaps,
regulatory role in the correct assembly of P bodies. We assume
that this role is more involved in the regulation of the process,
because P bodies formed in Dscp160 strains under glucose
starvation and also because stress granules appeared under heat
stress.
The association of P body components with polysomes is,
perhaps, not surprising. Different laboratories have previously
proposed a model of dynamic equilibrium in which P body
formation is directly coupled to translation attenuation (Coller
and Parker, 2005; Franks and Lykke-Andersen, 2008). The most
plausible way to achieve this coupling would be through a direct
interaction. In addition, influencing the phosphorylation state of
Dcp2 could be a part of the regulation of the dynamic
equilibrium. Dcp2 is predominantly in the phosphorylated state
on membrane-associated polysomes, whereas the phosphorylated
Fig. 7. Pseudo P bodies are formed in Dscp160 cells. (A) Cycloheximide
inhibits the formation of Dcp2-positive foci. Dcp2–GFP expressing cells were
grown at 23˚C to mid-log phase and then cycloheximide was added to a final
concentration of 100 mg/ml for 10 min before imaging. In all cases, few, if
any, Dcp2-positive foci were observed upon addition of cycloheximide,
indicating that the Dcp2-containing foci contained RNA. (B) Pseudo P bodies
are formed in Dscp160 cells. To test if the Dcp2 containing foci were bona
fide P bodies, either BFR1 or SCP160 was deleted from strains that
expressed Edc3–GFP, Scd6–GFP or Dhh1–GFP . Although multiple foci
were observed in Dbfr1 cells for all markers, very few foci were observed in
Dscp160 cells. (C) Quantification of the Edc3–GFP-, Scd6–GFP- and Dhh1–
GFP-positive foci observed in B. ***P,0.001. For a description of the
quantification, see Fig. 5B. (D) Starvation induces Dcp2-positive foci. Cells
containing Dcp2–GFP were grown to mid-log phase and then incubated in
rich medium without a carbon source (2D) for 10 min before imaging. Bright
Dcp2-positive foci were observed in wild-type (WT), Dbfr1 and Dscp160 cells.
In Dscp160 cells, foci of different sizes were observed. (E) Quantification of
the Dcp2–GFP foci observed under conditions of starvation in D. ***P,0.001.
Scale bars: 5 mm.
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and non-phosphorylated forms of Dcp2 are present in the soluble
pool of polysomes. Phosphorylation of Dcp2 is required for the
assembly of P bodies, which might influence the decay of some
mRNAs (Yoon et al., 2010). Because P bodies are in close
proximity to the ER, the phosphorylation state of Dcp2 might
represent a ‘primed state’ for P body formation. Moreover, the P
body components Dhh1 and Pat1 have been shown to be
translational repressors, indicating that there might be a
feedback mechanism between P bodies and ribosomes (Franks
and Lykke-Andersen, 2008; Pilkington and Parker, 2008).
Scp160 and Bfr1 are, most likely, not the only proteins that can
restrict the access of P body components to polysome-associated
mRNA. Moreover, they are not essential for the association of P
body components with polysomes, or the localization of P bodies
close to the ER. Still, it is noteworthy that Scp160 is
predominantly associated with membrane-bound polysomes
(Weber et al., 1997). Thus, it cannot be excluded that Scp160
has some role in P body localization to the ER. It has been
established that Scp160 only binds to a subset of mRNAs (Gelin-
Licht et al., 2012; Hogan et al., 2008; Li et al., 2003), and a
biological role for the mRNA–Scp160 interaction has been
demonstrated for ASH1 mRNA localization and pheromone
sensing (Gelin-Licht et al., 2012; Irie et al., 2002; Trautwein
et al., 2004). Importantly, Scp160 has been shown to bind DHH1
mRNA and is required for efficient translation of this message (Li
et al., 2003). Thus, Scp160 could be part of a regulatory loop that
controls the translation of specific messages. In the case of Dhh1,
however, we could not detect a difference in the protein levels
in Dscp160 cells (supplementary material Fig. S4). This role
could be regulated by phosphorylation because Scp160
is phosphorylated upon inhibition of the TOR complex by
rapamycin, mimicking amino acid starvation (Soulard et al.,
2010). In addition, Scp160 is part of a complex that contains
Eap1, a negative regulator of translation (Cosentino et al., 2000;
Mendelsohn et al., 2003). In fact, the Smy2, Eap1, Scp160, Asc1
(SESA) complex has been shown to act as a translational
repressor of the POM34 mRNA in response to spindle pole body
(SPB) duplication defects (Sezen et al., 2009). Pom34 is a
component of the nuclear pore complex that plays a role in the
insertion of the SPB into the nuclear envelope.
Scp160 appears to have multiple cellular functions – Scp160
controls ploidy (hence the name Saccharomyces protein
controlling ploidy) (Wintersberger et al., 1995), it is required
for the asymmetric localization of mRNAs (Gelin-Licht et al.,
Fig. 8. Scp160 and Bfr1 inhibit P body
formation under normal growth conditions.
In wild-type cells under normal growth
conditions, Scp160 and Bfr1 protect RNA at
polysomes. Scp160 interacts with RNA and P
body components and leaves P bodies in a
‘waiting’ position while still inhibiting P body
formation. In Dbfr1 cells, Scp160 is not
efficiently recruited to the polysomes and
cannot properly protect the RNA, thus,
allowing P body components to access RNAs.
In Dscp160, Bfr1 can, to an extent, be
recruited to polysomes, but without Scp160,
proper P body assembly cannot occur, leading
to the formation of pseudo P bodies.
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2012; Irie et al., 2002; Trautwein et al., 2004) and is part of a
translational repressor complex (Sezen et al., 2009). Scp160
might also act as a signaling platform on ribosomes to control the
translation of specific mRNAs (Baum et al., 2004), as it has been
shown to act as an effector of a G-protein in the mating response
pathway (Guo et al., 2003) and contributes to the regulation of
telomere silencing (Marsellach et al., 2006). Furthermore, here,
we show that Scp160 negatively regulates P body formation in
the absence of stress and might be a novel P body component.
How can all of these functions be performed by one protein?
Scp160 could be part of different complexes that regulate Scp160
functions and recruit it to the correct site of function; such an
adaptor function could be performed by Bfr1. Scp160 requires
Bfr1 for efficient polysome association, and Bfr1 might recruit
the SESA complex to the SPB (Sezen et al., 2009). However,
Bfr1 must have additional functions, besides being an Scp160
interactor because overexpression of BFR1 in the Dscp160 strain
was sufficient to alleviate the pseudo P body phenotype, and the
concomitant loss of BFR1 and SCP160 showed a strong reduction
of phosphorylated Dcp2 on soluble polysomes. Bfr1 might
directly interact with P body components, although with a lower
affinity than Scp160. Overexpression of BFR1 could, potentially,
increase its interaction with P body components and maintain the
P body components in the ‘waiting’ position.
In addition, the localization of ASH1 mRNA at the bud tip is
not only dependent on Scp160 but also on Bfr1 and ribosomes
(Irie et al., 2002; Trautwein et al., 2004). Thus, it is conceivable
that Bfr1 is the adaptor for complexes that are involved in
translation activation and repression. Clearly, Scp160 must have
other adaptor proteins to fulfill its Bfr1-independent roles as a G
protein effector or in the silencing of telomeres.
Scp160 is conserved in species up to human, and the closest
homologues are vigilin (also known as HDLBP) and the fragile X
syndrome protein FMRP (also known as FMR1) (Currie and Brown,
1999; Weber et al., 1997). Vigilin has been proposed to have a role
in cytoplasmic mRNA metabolism in Drosophila and human cell
lines (Goolsby and Shapiro, 2003) and to protect vitellogenin
mRNA from degradation by the mRNA endonuclease PMR-1 in
Xenopus (Cunningham et al., 2000). In addition, vigilin binds to the
mRNA of the proto-oncogene c-fms and inhibits its translation,
thereby relieving suppression of breast cancer cell proliferation
(Cao et al., 2004; Woo et al., 2011). These functions might be
regulated in a similar manner through binding to polysomes,
because, akin to Scp160, vigilin binds to ribosomes through its C-
terminal tail (Vollbrandt et al., 2004). Furthermore, the second
mammalian homologue of Scp160 FMRP binds to a subset of
mRNAs, and the I304N mutation, which was first described in an
fragile X syndrome (FXS) patient, reduces the association of the
protein with mRNAs and polysomes (Ascano et al., 2012; Feng
et al., 1997; Siomi et al., 1994). Therefore, it is also conceivable that
the function of Scp160 to control the translation of a subset of
mRNAs is also conserved in vigilin and FMRP.
MATERIALS AND METHODS
Yeast methods
Standard genetic techniques were used throughout (Sherman, 1991). All
modifications were carried out chromosomally, with the exceptions listed
below. Chromosomal tagging and deletions were performed as described
previously (Knop et al., 1999; Knop et al., 1999; Gueldener et al., 2002;
Gueldener et al., 2002). For co-staining of the ER, the cells were
transformed with the plasmid pSM1959 (with selectable marker LEU2)
carrying Sec63–RFP (kindly provided by Susan Michaelis, Johns
Hopkins University, Baltimore, MD). pRP1661 (with selectable marker
URA3) encoding Pub1–mCherry and pRP1575 (with selectable marker
TRP1) encoding Edc3–mCherry were provided by Roy Parker
(University of Colorado, Boulder, CO). The plasmid pMS449 carrying
the DC4 truncation of Scp160 was obtained from Matthias Seedorf
(ZMBH Heidelberg, Germany). The plasmid pTEF-Glo3-FLAG (with
selectable marker LEU2) was created through amplification of the GLO3
gene using the primers Glo3-6F and Glo3-11R (59-GCAATTTAGGA-
TCCAC-ATAGCGACAATGAG-39 and 59-GAGAAAATTCTCGAGA-
TTTTCTTAAGTAG-39, respectively) and the resulting fragment was
cloned using BamHI and XhoI into pcDNA3.1 with a C-terminal FLAG
tag.
The C-terminal FLAG tag was obtained through PCR of the plasmid
pcDNA3.1+the Glo3-FLAG construct with the primers Glo3-6F and
Glo3-10R (59-GGCAAACTGCAGATGGCTG-39). The resulting PCR
fragment was digested with BamHI and PstI, and ligated into vector
p425TEF. The final plasmids were confirmed by sequencing. The strains
used in this study are listed in supplementary material Table S1.
HBH-purification
The HBH purification was carried out as previously described by
Tagwerker and colleagues (Tagwerker, et al., 2006) with modifications.
Cells that expressed Dcp2–HBH or Scd6–HBH were grown to mid-to-
late log phase at 23 C˚ then shifted for 1 h to 37 C˚. The cells were fixed
by adding 37% formaldehyde to a final concentration of 1% and
incubating at room temperature for 2 min with gentle agitation. The
formaldehyde was quenched for 5 min by the addition of glycine to a
final concentration of 1.25 mM. The cells were harvested (4700 g for
3 min at 4 C˚), washed in 50 ml ice-cold double distilled H2O, pooled,
sedimented by centrifugation (5 min at 3000 g), flash frozen in liquid
nitrogen and stored at 280 C˚. The cells were thawed and resuspended in
2 ml of buffer 1 (50 mM NaPi pH 8.0, 8M urea, 300 mM NaCl 20 mM
imidazole, 0.5% Tween-20) per gram of yeast cell pellet. Per 2 ml screw
capped tube containing 500 ml glass beads, 1 ml of the cell suspension
was added. Lysis was performed in a FastPrep instrument four times for
45 seconds each at 4 C˚. The glass beads and cell debris were cleared with
a slow spin (1300 g for 10 min at 4 C˚), and the supernatant was removed
and pooled. The supernatants were spun at 20,000 g for 15 min at 4 C˚
and the resulting pellets were resuspended in 500 ml buffer 1 with the
addition of 1% Tween-20. 2.5 ml of Ni-NTA slurry that had been washed
in buffer 1 was added to the pooled lysates and rotated overnight at room
temperature. The tubes were spun at room temperature for 3 min at 2500
g and washed with 10 ml buffer 1. The tubes were spun as before and a
series of 10 ml washes and spins were sequentially performed (buffer 2:
50 mM NaPi pH 6.4, 8 M urea, 300 mM NaCl, 0.5% Tween-20; buffer
3: 50 mM NaPi pH 8.0, 8 M urea, 300 mM NaCl, 0.5% Tween-20,
20 mM imidazole; buffer 4: 50 mM NaPi pH 8.0, 8 M urea, 300 mM
NaCl, 0.5% Tween-20, 40 mM imidazole). After the final wash and spin,
4 ml of elution buffer (50 mM NaPi pH 6.4, 8 M urea, 300 mM NaCl,
0.5% Tween-20, 300 mM imidazole) was added and rotated with the
beads for 45 min. The beads were spun down as before, the eluate was
collected, and the elution step was repeated. 300 ml streptavidin agarose
that had been washed in buffer 1 was added to the 8 ml of elute and
rotated for 2 h at room temperature. The slurry was then spun as before
and washed with 10 ml of buffer 6 (50 mM Tris-HCl pH 8.0, 8 M urea,
300 mM NaCl, 2% SDS). This step was then repeated with 10 ml buffer
7 (50 mM Tris-HCl pH 8.0, 8 M urea, 300 mM NaCl, 0.2% SDS). The
final wash was performed in buffer 8 (50 mM Tris-HCl pH 8.0, 8 M
urea, 300 mM NaCl) and the streptavidin agarose was resuspended in
1 ml buffer 8. The slurry was then washed three times with 1 ml 50 mM
Tris-HCl pH 8.0 with 0.1% SDS, and 50 ml of solution was left in the
tube after the final wash. To each tube, 0.25 ml of 1 mg/ml
Endoproteinase LysC (ELC) was added, and the tubes were placed at
37 C˚ with shaking. After 2 h, a further 0.25 ml of 1 mg/ml ELC was
added and the tubes were placed at 37 C˚ overnight with shaking. The
tubes were briefly spun down and the supernatant was collected. The
beads were extracted twice with of 50 mM Tris-HCl pH 8.0 with 0.1%
SDS (in a volume of 200 ml followed by 100 ml). The three samples were
pooled and dried in a Speed-Vac concentrator. The peptides were
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resuspended in 400 ml BS (85% acetonitrile, 10 mM ammonium acetate
with formic acid pH 3.5) and loaded twice on a HILIC TopTip PolyLC
spin column (PolyLC) that had been equilibrated three times with
50 ml ES (5% acetonitrile, 10 mM ammonium acetate with formic acid
pH 3.5) and three times with 50 ml BS. The column was washed three
times with 50 ml BS and the peptides were eluted four times with 25 ml
ES. All elutions were pooled and dried in a Speed-Vac concentrator. The
peptides were then resuspended in 50 ml of 50 mM NH4HCO3 and
subjected to trypsin digest with 0.5 ml 1 mg/ml trypsin (Promega) for 6 h
at 37 C˚. Mass spectrometric analysis was performed using LC-MS/MS
(Orbitrap).
Fluorescence microscopy
Cells were grown in yeast extract peptone dextrose (YPD) medium to
early-log phase and then either shifted to 37 C˚ for 1 h or subjected to
various stresses, as indicated. The cells were spun at 3000 g for 3 min
and resuspended in Hartwell’s complete (HC) medium and immobilized
on concanavalin-A-coated slides. For strains harboring the pTEF-Glo3-
FLAG plasmid, the cells were grown in HC medium that lacked leucine.
In the methionine experiments, cells were grown at 30 C˚ in YPD
containing 100 mg/ml methionine for 72 h and maintained at an OD600 of
between 0.2 and 1.0 through continuous dilution.
Fluorescence was monitored with an Axiocam mounted on an
Axioplan 2 fluorescence microscope (Carl Zeiss, Oberkochen,
Germany) by using Axiovision software. Image processing was
performed using Image J and Adobe Photoshop CS5 (San Jose, CA).
For counting, a minimum of 200 cells from at least three independent
experiments was counted per condition. In the quantification graphs, the
size of the box is determined by the 25th and 75th percentiles, the
whiskers represent the 5th and 95th percentiles, the lines and the triangles
mark the median and the mean, respectively.
Immunoelectron microscopy
Cells expressing Dcp2–9Myc were grown to early-log phase at 23 C˚ and
then shifted to 37 C˚ for 1 h. The cells were fixed and treated for
immunoelectron microscopy as described previously (Prescianotto-
Baschong and Riezman, 2002). Secondary antibodies against goat anti-
rabbit IgG that had been coupled to 10-nm gold particles
(BBInternational, Cardiff, United Kingdom) were used to detect the
binding of polyclonal rabbit antibodies that recognise Myc (Abcam,
Cambridge, MA).
Immunoprecipitations
Immunoprecipitations were performed similarly as described previously
(Sezen et al., 2009). Twenty OD600 units of logarithmically growing cells
that had been grown in YPD and subjected to the various stresses,
as indicated, were disrupted with glass beads in 300 ml of
immunoprecipitation buffer [50 mM triethanolamine pH 6.0, 150 mM
KCl, 5 mM EDTA, 5 mM EGTA, protease inhibitor tablet (Roche),
1 mM PMSF and 1 mM benzamidine]. The lysates were incubated with
1% Triton X-100 for 10 min at 4 C˚, and the extracts were cleared by
centrifugation (3000 g for 10 min at 4 C˚). An aliquot was removed that
served as the input control, and the remainder of the extract was
incubated with a monoclonal antibody against FLAG peptide (M2,
Invitrogen) and magnetic bead slurry (Dynal) for 2.5 h at 4 C˚. The beads
were washed three times with immunoprecipitation buffer containing
0.1% Triton X-100. The beads were resuspended in sample buffer and
analyzed by immunoblotting.
For the RNase A treated samples, after the extracts had been cleared by
centrifugation, they were treated with 40 U of RNase inhibitor (Promega)
or 1 mg/ml RNase A and incubated for 1 h at 4 C˚. The extracts were then
spun for 3 min at 3000 g, and the supernatant was used for the
immunoprecipitation as described above.
Antibodies
Antibodies were used to detect the following epitope tags and proteins:
Myc (9E10, 1:1000, Sigma-Aldrich), hemagglutinin (HA11, 1:1000,
Covance, Princeton, NJ), Scp160 (1:1000), Bfr1 (1:1000), Rpl16a
(1:1500, a gift from Michael N. Hall, Biozentrum, Basel, Switzerland)
and Sec61 (1:10,000, a gift from Martin Spiess, Biozentrum, Basel,
Switzerland).
Flotation of P bodies
Flotation of ER membranes was performed as described previously
(Schmid et al., 2006). The equivalent of 50 OD600 units was converted
into sphereoplasts at 37 C˚ and lysed by Dounce homogenization in 3 ml
lysis buffer [20 mM HEPES in KOH, pH 7.6, 100 mM sorbitol, 100 mM
KAc, 5 mM Mg(Ac)2, 1 mM EDTA, 1 mM dithiothreitol, 100 mg/ml
cycloheximide, protease inhibitors]. After the removal of cellular debris
(5 min, 300 g), the membranes were pelleted by centrifugation (10 min,
13,000 g), resuspended in 2 ml lysis buffer containing 50% sucrose and
layered on top of 2 ml 65% sucrose in lysis buffer. Two additional 5 ml
and 2 ml cushions (40% and 0% sucrose) were layered on top. The step
gradient was spun in a TST41.14 rotor for 16 h at 28,000 g. After
centrifugation, 1 ml fractions were collected from each of the cushions
and the interfaces, and were then precipitated with trichloroacetic acid
(TCA). The samples were analyzed by SDS-PAGE and immunoblotting.
Polysome profile analysis
Preparations of polysomes were performed as described previously (de la
Cruz et al., 1997) on 4–47% sucrose gradients that had been prepared
using a Gradient Master (Nycomed Pharma, Westbury, NY). Gradient
analysis was performed using a gradient fractionator (Labconco, Kansas
City, MO) and the A¨cta FPLC system (GE Healthcare) and continuously
monitored at A254. Fractions were precipitated with 10% TCA, separated
using SDS-PAGE and analyzed by western blotting.
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